Zobrazeno 1 - 10 of 191 pro vyhledávání: '"Tino F, Schwarz"'
2
Akademický článek
Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions
Autor: Tomas Jelinek, Tino F. Schwarz, Emil Reisinger, Peter Malfertheiner, Eve Versage, Esther Van Twuijver, Matthew Hohenboken
Publikováno v: Vaccines, Vol 12, Iss 5, p 481 (2024)
Influenza pandemics pose a serious risk to the global population, with the potential for high morbidity and mortality. An adjuvanted H5N1 vaccine (aH5N1) has been approved for prophylaxis against the avian influenza virus H5N1, which is a likely caus
Externí odkaz: https://doaj.org/article/223467b1d8454f8893e18e69cd60bc1f
Zobrazit plný text záznamu
3
Akademický článek
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years
Autor: Tino F. Schwarz, Li-Min Huang, Alejandra Valencia, Falko Panzer, Cheng-Hsun Chiu, Annabelle Decreux, Sylviane Poncelet, Naveen Karkada, Nicolas Folschweiller, Lan Lin, Gary Dubin, Frank Struyf
Publikováno v: Human Vaccines & Immunotherapeutics, Vol 15, Iss 7-8, Pp 1970-1979 (2019)
This study assessed long-term immunogenicity and safety following 3 doses of AS04-adjuvanted human papillomavirus (HPV)-16/18 L1 virus-like particle (VLP) vaccine in females 10–14 years old. Girls included in the immunogenicity subset in the primar
Externí odkaz: https://doaj.org/article/12db5ea015de4256acac886bf78b7c59
Zobrazit plný text záznamu
4
Akademický článek
Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
Autor: Tino F. Schwarz, Ulrich Behre, Thomas Adelt, Matthias Donner, Pemmaraju V. Suryakiran, Winnie Janssens, Narcisa Mesaros, Falko Panzer
Publikováno v: Human Vaccines & Immunotherapeutics, Vol 15, Iss 1, Pp 235-241 (2019)
We evaluated antibody persistence against hepatitis B virus (HBV) in adolescents previously vaccinated with a hexavalent diphtheria-tetanus-acellular pertussis-HBV-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine (DTPa-HBV-IPV/H
Externí odkaz: https://doaj.org/article/49f1fb2f8a7d468dad1697e7a43c639b
Zobrazit plný text záznamu
5
Weiterentwickelte zielgruppenorientierte Influenzaimpfstoffe – Neue Evidenz zeigt höhere Effektivität bei älteren Erwachsenen
Autor: Markus Frühwein, Jörg Schelling, Klaus Wahle, Dietmar Beier, Anja Kwetkat, Tino F. Schwarz
Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 148:556-562
ZusammenfassungDie saisonale Influenza verursacht eine signifikante Krankheitslast in der deutschen Bevölkerung und geht mit hohen volkswirtschaftlichen Kosten einher. Personen ab 60 Jahren sind aufgrund von Immunseneszenz und chronischen Erkrankung
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::922acfd141c213f0df4ec4773854b5a6
https://doi.org/10.1055/a-2032-1368
Zobrazit plný text záznamu
7
Akademický článek
Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
Autor: Tino F. Schwarz, Stephanie Volpe, Gregory Catteau, Roman Chlibek, Marie Pierre David, Jan Hendrik Richardus, Himal Lal, Lidia Oostvogels, Karlis Pauksens, Stephanie Ravault, Lars Rombo, Gerard Sonder, Jan Smetana, Thomas Heineman, Adriana Bastidas
Publikováno v: Human Vaccines & Immunotherapeutics, Vol 14, Iss 6, Pp 1370-1377 (2018)
Background: In adults aged ≥60 years, two doses of the herpes zoster subunit vaccine (HZ/su; 50 µg varicella-zoster virus glycoprotein E [gE] and AS01B Adjuvant System) elicited humoral and cell-mediated immune responses persisting for at least si
Externí odkaz: https://doaj.org/article/1fea19af99134a6fa6c0023b1d606077
Zobrazit plný text záznamu
8
Akademický článek
Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults
Autor: Carine Claeys, Mamadou Drame, José García-Sicilia, Khalequ Zaman, Alfonso Carmona, Phu My Tran, Mariano Miranda, Federico Martinón-Torres, Franck Thollot, Michael Horn, Tino F. Schwarz, Ulrich Behre, José M. Merino, Iwona Sadowska-Krawczenko, Henryk Szymański, Peter Schu, Elisabeth Neumeier, Ping Li, Varsha K. Jain, Bruce L. Innis
Publikováno v: BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background GSK has modified the licensed monovalent bulk manufacturing process for its split-virion inactivated quadrivalent influenza vaccine (IIV4) to harmonize the process among different strains, resulting in an increased number of finis
Externí odkaz: https://doaj.org/article/9dc36b718bfa4646a1acdefeca5a764f
Zobrazit plný text záznamu
10
LB745. Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)
Autor: Michael G Ison, Alberto Papi, Joanne M Langley, Dong-Gun Lee, Isabel Leroux-Roels, Federico Martinon-Torres, Tino F Schwarz, Richard N Van Zyl-Smit, Nancy Dezutter, Nathalie De Schrevel, Laurence Fissette, Marie-Pierre David, Marie Van Der Wielen, Lusine Kostanyan, Veronica Hulstrøm
Publikováno v: Open Forum Infectious Diseases. 9
Background RSV-associated acute respiratory infections (ARI), particularly lower respiratory tract diseases (LRTD), present a significant disease burden in older adults. Currently, there are no approved vaccines against RSV. We present results from a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bc399db332740886d9965d408e630f2b
https://doi.org/10.1093/ofid/ofac492.1868
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje